期刊文献+

E6-AP基因在乳腺癌MDA-MB-231细胞中调节膜联蛋白A2的表达 被引量:3

E6-AP gene regulates Annexin A2 expression in breast cancer MDA-MB-231 cells
原文传递
导出
摘要 目的检测E6-AP基因及膜联蛋白A2(Annexin A2)在乳腺癌MDA-MB-231细胞中的表达,探讨其对癌细胞增殖、凋亡及浸润转移的影响。方法设计1条无关序列Negative-siRNA作为阴性对照组和针对E6-AP基因的3条特异性E6-AP-siRNAs片段转染至MDA-MB-231细胞内作为实验组,未经处理细胞作为空白对照组,加入脂质体处理的细胞为脂质体组,利用RT-PCR检测干扰E6-AP后在MDA-MB-231细胞中E6-AP和Annexin A2 mRNA相对表达水平。选择出转染效率最高的E6-APsiRNA1组及阴性对照组、空白对照组继续行后续实验。Western blot检测干扰E6-AP后E6-AP和Annexin A2在MDA-MB-231细胞中的蛋白的相对表达水平。利用CCK-8试剂盒法、流式细胞术、Transwell小室侵袭实验分别检测干扰E6-AP后MDA-MB-231细胞的增殖、凋亡、侵袭能力。基因的mRNA及蛋白表达水平、细胞凋亡率及细胞数的组间比较采用方差分析,两两比较采用LSD法,吸光度比较采用重复测量的方差分析。结果转染72 h后,E6-AP基因干扰后各实验组(E6-AP-siRNA1组、E6-AP-siRNA2组、E6-AP-siRNA3组)及空白对照组、阴性对照组及脂质体组中的E6-AP mRNA相对表达水平分别为0.159±0.003、0.325±0.006、0.229±0.007、0.593±0.031、0.594±0.012、0.612±0.016,Annexin A2 mRNA相对表达水平分别为0.929±0.017、1.013±0.082、0.992±0.024、1.341±0.037、1.323±0.010、1.326±0.012,差异均有统计学意义(F=850.792、417.447,P均<0.050)。转染72 h后,E6-AP-siRNA1组、空白对照组和阴性对照组中E6-AP及Annexin A2蛋白相对表达水平为分别为0.271±0.017、0.492±0.018、0.477±0.016及0.447±0.034、0.887±0.022、0.849±0.033,组间差异均有统计学意义(F=256.850、350.149,P均<0.050)。转染24、48、72、96 h后,E6-AP-siRNA1组、阴性对照组和空白对照组间比较,不同时间点之间比较,细胞吸光度差异均有统计学意义(F=524.828,P<0.001;F=904.079,P<0.001);分组与时间点存在交互作用(F=28.116,P<0.001)。转染72 h后,空白对照组、阴性对照组、E6-AP-siRNA1组的凋亡率分别为2.959±0.117、3.097±0.070、10.812±0.199,组间差异有统计学意义(F=3110.005,P<0.050)。Transwell检测E6-AP-siRNA1组、空白对照组、阴性对照组中细胞穿透Matrigel胶到达Transwell下室的细胞数分别为99±5、96±6、62±7,组间差异有统计学意义(F=55.404,P<0.001)。结论干扰E6-AP基因可使Annexin A2表达下调,同时可诱导MDA-MB-231细胞的凋亡,其增殖、侵袭能力也受到抑制。 Objective To study the expressions of E6-AP gene and Annexin A2in breast cancer MDA-MB-231cells,and explore their effects on the proliferation,apoptosis and invasion and metastasis of cancer cells.Methods Negative-siRNA was transfected into MDA-MB-231cells as negative control,3designed E6-AP-siRNA sequences were transfected into MDA-MB-231cells as experimental groups,the untreated cells served as blank control and the cells with liposome treatment served as liposome group.The mRNA expressions of E6-AP and Annexin A2in MDA-MB-231cells were detected by RT-PCR after E6-AP interference.The E6-AP-siRNA1group with the highest transfection efficiency,along with negative control group and blank control group,was selected for the following experiments.The protein expressions of E6-AP and Annexin A2in MDA-MB-231cells after E6-AP interference were detected by Western blot.
作者 侯令密 谢少利 陈茂山 李敬东 Emmanuel Ajedichiga Aduah 王明浩 邓世山 幸天勇 赵小波 Hou Lingmi;Xie Shaoli;Chen Maoshan;Li Jingdong;Emmanuel Ajedichiga Aduah;Wang Minghao;Deng Shishan;Xing Tianyong;Zhao Xiaobo(Department of Thyroid and Breast Surgery,Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan Province, China;Institute of Hepatobiliarypancreatic-intestinal Diseases,Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan Province, China;Department of Breast and Thyroid Surgery,Suining Central Hospital, Suining 629000, Sichuan Province, China;Breast Disease Center, Southwest Hospital,Third Military Medical University, Chongqing 400016,China;Department of Anatomy, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan Province, China)
出处 《中华乳腺病杂志(电子版)》 CAS CSCD 2016年第6期326-332,共7页 Chinese Journal of Breast Disease(Electronic Edition)
基金 国家自然科学基金资助项目(81172496) 四川省教育厅重点项目(13ZA0228) 四川省科技厅科技创新苗子工程项目(2016060)
关键词 乳腺肿瘤 细胞增殖 细胞凋亡 肿瘤侵润 Breast neoplasms Cell proliferation Apoptosis Neoplasm invasiveness
  • 相关文献

参考文献1

二级参考文献23

  • 1侯令密,幸天勇,邓世山.AnnexinA2与乳腺癌关系的研究进展[J].中华临床医师杂志(电子版),2011,5(14):4206-4208. 被引量:2
  • 2幸天勇,侯令密,汪建国,赵小波,高砚春,邓世山.膜联蛋白A2在人乳腺癌组织中的差异表达及意义[J].中华临床医师杂志(电子版),2011,5(18):5310-5313. 被引量:2
  • 3Dhillon S. Trastuzumab emtansine: a review of its use in patients with HER2-positive advanced breast cancer previously treated with trastuzumab-based therapy[J]. Drugs, 2014, 74 (6) : 675-686.
  • 4Hagan CR, Lange CA. Molecular determinants of context- dependent progesterone receptor action in breast cancer [J]. BMC Med, 2014, 12: 32.
  • 5Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine[J]. NEnglJ Med, 2012, 366(6): 489-491.
  • 6Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or earboplatin-paclitaxel in pulmonary adenoeareinoma[J]. N Engl J Med, 2009, 361(10): 947-957.
  • 7Knutson TP, Lange CA. Tracking progesterone receptor- mediated actions in breast cancer[J]. Pharmacol Ther, 2014, 142(1) : 114-125.
  • 8Sachdev D. Targeting the type I insulin-like growth factor system for breast cancer therapy[J]. Curt Drug Targets, 2010, 11(9): 1121-1132.
  • 9Shimizu A, Nakayama H, Wang P, et al. Netrin-i promotes glioblastoma cell invasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding protein [J]. J Biol Chem, 2013, 288(4): 2210-2222.
  • 10Zhang Q, Zhao Z, Ma Y, et al. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma[J].Urol Oncol, 2014, 32(6): 798-805.

共引文献1

同被引文献11

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部